Posterior Reversible Encephalopathy Syndrome (PRES)

Posterior Reversible Encephalopathy Syndrome (PRES) is a clinicoradiological syndrome characterized by:

  • Acute neurological symptoms
  • Vasogenic cerebral edema (predominantly posterior circulation territory)
  • Reversible changes on neuroimaging

It is not always posterior and not always reversible

  • Frontal lobes may be involved
  • Basal ganglia involvement possible
  • Brainstem and cerebellar involvement possible
  • Can even be unilateral

Pathophysiology of PRES

Two major competing (but complementary) theories:

1️⃣ Failure of Cerebral Autoregulation (Hyperperfusion Theory)

When BP exceeds autoregulatory limits:

  • Loss of arteriolar vasoconstriction
  • Hyperperfusion
  • Blood–brain barrier breakdown
  • Extravasation of plasma vasogenic edema

Posterior circulation more vulnerable because:

  • Less sympathetic innervation
  • Vertebrobasilar system less protected


2️⃣ Endothelial Dysfunction Theory (More accepted in ICU patients)

Seen in:

  • Sepsis
  • Cytotoxic drugs
  • Eclampsia
  • Transplant patients

Mechanism:

  • Endothelial activation
  • Capillary leakage
  • Vasogenic edema
  • Sometimes microthrombosis


Etiology & Risk Factors 

1️⃣ Hypertensive Emergencies

  • Malignant hypertension
  • Rapid BP fluctuations

2️⃣ Eclampsia / Preeclampsia

  • Classic board question

3️⃣ Sepsis / Septic Shock

  • Endothelial injury
  • Cytokine storm

4️⃣ Renal Failure

  • Fluid overload
  • Uremia
  • Dialysis disequilibrium

5️⃣ Immunosuppressive Drugs

  • Cyclosporine
  • Tacrolimus
  • Chemotherapy
  • Anti-VEGF agents

6️⃣ Autoimmune Disease

  • SLE
  • TTP


Clinical Presentation

Classic Tetrad

  1. Headache (throbbing)
  2. Seizures (often generalized tonic–clonic)
  3. Visual disturbances
  4. Altered sensorium


Detailed Symptomatology

Feature

Explanation

Seizures

Most common presentation (~60–80%)

Cortical blindness

Occipital involvement

Visual hallucinations

Parieto-occipital cortex

Confusion

Diffuse involvement

Status epilepticus

ICU presentation

Focal deficits

If hemorrhage present


Imaging 

CT Brain(Not sensitive)

  • May be normal early
  • Hypodensities in posterior regions


MRI Brain 

Typical Findings:

  • Bilateral symmetrical
  • Parieto-occipital white matter hyperintensity
  • FLAIR hyperintensity
  • No restricted diffusion (vasogenic, not cytotoxic)


DWI / ADC Pattern

  • Vasogenic edema ADC
  • Cytotoxic edema ADC (poor prognosis)

 Important  differentiation from ischemic stroke.


Atypical Imaging Patterns

  • Frontal lobe involvement
  • Basal ganglia involvement
  • Brainstem involvement
  • Hemorrhagic PRES (15–20%)


Differential Diagnosis

Condition

Key Differentiator

Ischemic stroke

Diffusion restriction

RCVS(Reversible Cerebral Vasoconstriction Syndrome)

Thunderclap headache + angiographic vasospasm

CNS vasculitis

Vessel wall enhancement

Encephalitis

CSF abnormal

Toxic leukoencephalopathy

Drug exposure history


Critical Care Management

Step 1: Control Blood Pressure

Goal:

  • Reduce MAP by 20–25% in first hour
  • Avoid rapid overcorrection

Preferred agents:

  • Nicardipine infusion
  • Labetalol infusion

Avoid:

  • Nitroprusside ( ICP risk)


 Step 2: Seizure Management

Follow status epilepticus protocol:

  1. Benzodiazepines
  2. Levetiracetam (preferred in ICU)
  3. Valproate (avoid in liver failure)
  4. Phenytoin (less preferred)

Long-term AED usually not required if reversible.


Step 3: Remove Trigger

  • Stop offending drug (tacrolimus, cyclosporine)
  • Deliver fetus in eclampsia
  • Treat sepsis aggressively
  • Dialysis optimization in renal failure


 Step 4: ICP Control (if needed)

  • Head elevation
  • Osmotherapy (mannitol / hypertonic saline)
  • Controlled ventilation if intubated


Complications

  • Intracerebral hemorrhage
  • Status epilepticus
  • Brain herniation (rare)
  • Persistent deficits (if delayed treatment)


 Is It Always Reversible?—>No.

Reversibility depends on:

  • Early recognition
  • Prompt BP control
  • Removal of trigger
  • Absence of cytotoxic edema

Poor prognostic markers:

  • Diffusion restriction
  • Brainstem involvement
  • Severe hypertension
  • Delayed management


Prognosis

  • Most improve within 1 week
  • Radiological resolution within weeks
  • Mortality: ~5–15% in ICU cohorts
  • Recurrence possible


PRES vs RCVS 

Feature

PRES

RCVS

BP

High

Often normal

Headache

Gradual

Thunderclap

Angiography

Normal

Segmental vasoconstriction

Edema

Vasogenic

Minimal

Trigger

HTN, drugs

Postpartum, vasoactive drugs


Reversible Cerebral Vasoconstriction Syndrome (RCVS)